Target intelligence / Profile preview

E3 ubiquitin-protein ligase TRIM15 (TRIM15)

Target
TRIM15
Molecular classification
Enzyme, E3 ubiquitin ligase, Tripartite motif family protein
01

Overview

E3 ubiquitin-protein ligase TRIM15 is a cytoplasmic enzyme belonging to the tripartite motif (TRIM) family, characterized by three zinc-binding domains (RING finger, B-box type 1, B-box type 2) and a coiled-coil region[1][2][3]. TRIM15 acts as an E3 ubiquitin ligase, regulating the ubiquitin-proteasome pathway to control protein degradation. It promotes cell proliferation and metastasis in various cancers by targeting substrates such as Keap1 for proteasomal degradation, thereby modulating key cellular pathways including the Nrf2 antioxidant pathway and ERK1/2 signaling[2][3][5]. TRIM15 also functions in innate immunity, contributing to interferon induction and viral defense by modulating pathways like RIG-I-MAVS and interacting with focal adhesion components to regulate cell migration and chemotaxis[3][6][7]. Its dysregulation has been linked to oncogenesis, making it a potential therapeutic target, especially in lung, melanoma, and pancreatic cancers[2][5].

Other names
Tripartite motif-containing protein 15RNF93ZNF178ZNFB7RING finger protein 93Zinc finger protein 178Zinc finger protein B7
02

Mechanism of action

Ubiquitination and proteasomal degradation of substrate proteins; activation of MAPK/ERK pathway; degradation of Keap1 to activate Nrf2 pathway

03

Biological functions

UbiquitinationInnate immune responseSignal transductionCell migrationApoptosisProtein degradationCell proliferationAntiviral response
04

Disease associations

CancerInflammationInfection
05

Safety considerations

Therapeutic challenges associated with broad biological roles and involvement in tumorigenesisrisk of affecting normal ubiquitin-proteasome system functions
06

Biomarkers

Potential diagnostic marker for gastric cancerupregulated in non-small cell lung cancer and pancreatic cancer progression

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase TRIM15 (TRIM15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM15 (TRIM15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call